Cellectis Security Sold Not Yet Repurchased (Quarterly) Analysis

Cellectis SA (CLLS)

3.90 -0.09 (-2.26%) USD | NASDAQ | Feb 20, 16:00

3.97 +0.07 (+1.79%) After-Hours: 20:00

View Security Sold Not Yet Repurchased (Quarterly) for CLLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Security Sold Not Yet Repurchased (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Security Sold Not Yet Repurchased (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Security Sold Not Yet Repurchased (Quarterly) Benchmarks

Start Trial

EDAP TMS SA	--
DBV Technologies SA	--
Ascendis Pharma A/S	--
Akari Therapeutics Plc	--
Biodexa Pharmaceuticals Plc	--